Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Terminated 3Active not recruiting 3Recruiting 2Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 24Lymphoma 11Lymphoma, Non-Hodgkin 9Prostatic Neoplasms 8Lymphoma, T-Cell, Peripheral 8Lymphoma, Follicular 7Leukemia 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Multiple Myeloma 5Neoplasms, Plasma Cell 4Lymphoma, Mantle-Cell 4Hodgkin Disease 3Burkitt Lymphoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Myasthenia Gravis 2Lymphoma, Large-Cell, Immunoblastic 2Immunoblastic Lymphadenopathy 2Subcutaneous panniculitis-like T-cell lymphoma 1Spinal Cord Neoplasms 1Recurrence 1Prostatic Neoplasms, Castration-Resistant 1Plasmablastic Lymphoma 1Pituitary Neoplasms 1Neoplasms, Experimental 1Neoplasms 1Neoplasm Metastasis 1Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel 1Neoadjuvant Therapy 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1

Interventions

Cyclophosphamide 17fludarabine 13Dexamethasone 12Cisplatin 11Rituximab 10Gemcitabine 9Paclitaxel 7Lenalidomide 7Decitabine 7Cytarabine 7Bendamustine Hydrochloride 7fludarabine phosphate 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Etoposide 6Carboplatin 6Bortezomib 6Radiotherapy 5Injections 5Azacitidine 5camrelizumab 4apatinib 4Valproic Acid 4Thalidomide 4Procarbazine 4Oxaliplatin 4Drug Therapy 4Antilymphocyte Serum 4tislelizumab 3pomalidomide 3liposomal doxorubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Recurrence × Prednisone × Clear all
NCT03321890 2017-10-26

Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Sun Yat-sen University

Phase 2 Unknown
102 enrolled
Lymphoid

Recurrence, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡